Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinqiao Yanshu Granules for Acute Pharyngitis
NCT06932328Phase 2Recruiting
- Sponsor
- Jianmin Pharmaceutical Group
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute pharyngitis (3 arms), sponsored by Jianmin Pharmaceutical Group. Primary endpoint: The disappearance rate of pharyngeal pain at 5 days. Started Mar 2025; status: recruiting.
02
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT06932328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06932328.